In Silico Structural Prediction of Human Steroid 5α-Reductase Type II

    March 2016 in “ Medicinal Chemistry Research ”
    Wiranpat Karnsomwan, Thanyada Rungrotmongkol, Wanchai De-Eknamkul, Supakarn Chamni
    Image of study
    TLDR Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.
    In 2016, researchers studied the structure of human steroid 5α-reductase type II, an enzyme linked to androgenic disorders like prostate cancer and androgenic alopecia. They used homology modeling to create a comparative structure of the enzyme, identifying a catalytic pocket and the transmembrane site. The structure was validated by docking studies of 30 known inhibitors, including finasteride and dutasteride. The model fit the membrane-associated character and showed reasonable docking results, suggesting it could be useful for steroid reductase drug design.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community risks with finasteride and dutasteride

      in Research/Science  142 upvotes 4 months ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 5 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 1 year ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.

    Related Research

    2 / 2 results